Understanding HER2 Low Breast Cancer

- Overview of HER2 Low Breast Cancer, Including What is HER2 Status - Diagnostic Testing: What is an Immunohistochemistry (IHC) Test or Fluorescence In Situ Hybridization (FISH) Test - The Role of the Pathologist - The Role of the Genetic Counselor - Standard Treatment Options, Including Targeted Therapy - How Biomarker Testing Informs Treatment Decisions - New Targeted Treatments - Updates on Investigational New Drugs in Clinical Trials: How Research Contributes to Treatment Options - What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain - Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns for HER2 Low Breast Cancer - Questions for Our Panel of Experts